Advertorial BRB PDP-2

Advertorial

Home > Dry Eyes > Viturea Astaxanthin Softgels

Doctors Exposed: 86% Of "Harmless" Dry Eye Cases Are Causing Permanent Blindness

Published on March 8, 2026

I've watched thousands of patients lose their vision because we're treating the surface while the real damage happens behind a barrier no drop can cross. By the time they realize it, the retinal cells are gone — and they don't grow back."

— Dr. Richard Tanaka, Board-Certified Ophthalmologist & Dry Eye Specialist

Chronic dry eye leads to progressive vision loss (and most patients don't know until it's too late)

Every time that burning sensation flares up in your eyes, the retinal cells behind a protective wall deep inside your eye are being destroyed by oxidative stress — completely unprotected.

That's because your eye has a physical barrier — called the blood-retinal barrier — that blocks virtually every drop, supplement, and treatment you've ever used from reaching the tissue that's actually deteriorating.

And it's been doing this for years. Silently. While you treated the surface.

In simple terms: untreated oxidative damage behind the barrier makes you blind, isolated, and trapped by failing vision.

That explains why my patient Diane Sorenson spent four years watching her life disappear.

Why her husband now has to read the mail to her because the fine print swims and blurs until she can't tell a bill from a birthday card.

Why she can't drive after dark anymore — the headlights create halos so thick she can't see the lane lines through them.

Why she quit her job as a paralegal because she couldn't look at a screen for more than 20 minutes without the burning becoming unbearable.

But the loss of independence was just the beginning.

Unchecked damage behind the blood-retinal barrier also increases your risk of:

Permanent retinal cell death — cells that never regenerate once destroyed

Accelerating vision loss that compounds with every unprotected month

Complete loss of night vision, contrast sensitivity, and the ability to read fine print

Total dependence on others for driving, reading, and navigating daily life

Diane didn't know any of this when she found herself crying at her computer at 10:47 AM, unable to see her screen clearly, waiting for the burning to subside so she could finish one more email before her vision failed completely.

As her researcher, I watched her spend over $9,200 trying every solution the medical system offered.

Preservative-free drops.

Restasis at $400 a month.

Warm compresses twice daily.

Omega-3 supplements.

Punctal plugs.

IPL treatments.

LipiFlow at $1,500 out of pocket.

A lifestyle she rebuilt around her failing eyes.

But nothing worked.

Because nothing she tried could cross the wall.

Until I discovered something that changed everything I thought I knew...

Dr. Tanaka's 23-Year Career Hits a Breaking Point

Dr. Richard Tanaka has spent more than two decades studying why conventional eye treatments fail at the cellular level.

Published in the Journal of Nutritional Ophthalmology. Cited in 14 peer-reviewed studies on antioxidant absorption in retinal tissue. Consultant to three supplement companies and two university research labs.

He thought he understood dry eye disease as well as anyone alive.

Then Diane walked into his research office on a referral from her ophthalmologist — who had run out of answers.

She moved carefully, squinting even though the blinds were drawn.

"My eye doctor says my retinas look like they belong to someone twenty years older than me," Diane said quietly.

"I've done everything he told me to. Drops four times a day. Omega-3 supplements. Warm compresses every night. I even tried Restasis — the prescription drops that cost $400 a month."

Her voice broke.

"I had to ask my husband to read my daughter's wedding invitation to me. My own daughter's wedding invitation."

"I'm 53 years old, Doctor."

"Am I going to be blind by the time she gets married?"

The Question That Changed How Researchers Think About Dry Eyes

Dr. Tanaka prescribed the standard treatment with confidence.

Preservative-free drops four times daily.

Warm compresses morning and night.

Continued omega-3 supplementation at a higher dose.

Referral to a specialist for evaluation of punctal plugs.

Lifestyle modifications — reduce screen time, increase humidity, limit time in air-conditioned environments.

Four months later, Diane was back.

Worse.

"I did everything you said," Diane told him, staring at the floor.

"I used the drops. I did the compresses. I took the omega-3s. I got the plugs."

"I quit my job to reduce screen time. I changed everything about how I live."

"But now I'm worse. I can't even do the things I could do four months ago."

"I used to at least be able to drive during the day.

Now I can't see clearly enough to feel safe behind the wheel at all."

Dr. Tanaka stared at Diane's file.

Classic case. Standard treatment prescribed. Everything done correctly according to protocol.

"Doctor," Diane continued.

"Are you telling me I just have to accept this? That I'll spend the rest of my life going blind? That I'll never see my grandchildren's faces clearly?"

That's when Dr. Tanaka realized everything he'd been recommending was aimed at the wrong target.

Despite his credentials, he'd been following treatment protocols instead of questioning the fundamental assumption underneath them:

That dry eye is a surface problem.

"Diane wasn't just my patient anymore. She was my wake-up call," Dr. Tanaka later confessed.

"I'd been prescribing surface treatments for a problem that lives behind a wall those treatments can never cross."

Dr. Tanaka made a decision that would change Diane's life:

"There has to be another way."

The Investigation That Changes Everything

Diane's case haunted Dr. Tanaka for weeks.

He drove back to his lab at 11 PM that night and started pulling every retinal study from the past decade — focusing not on what treatments DO, but on what they physically CANNOT do.

What he found wasn't new science. It had been published for years.

But nobody — not the supplement companies, not the ophthalmologists, not the $9.6 billion dry eye treatment industry — was connecting the dots.

The blood-retinal barrier — the wall between your bloodstream and your retinal cells — blocks approximately 98% of all treatments, supplements, and medications from ever reaching the tissue that's deteriorating.

This is basic ocular anatomy. Every ophthalmologist learns it in their first year of training.

But almost nobody connects it to why their patients' treatments keep failing.

Here's what made Dr. Tanaka angry:

Every dry eye clinic in America has the knowledge. Every ophthalmologist studied the barrier in medical school. They KNOW it exists.

"We know the wall is there," he revealed.

"We know it blocks virtually everything we prescribe."

"But then we send patients home with drops and compresses that can't cross it — and wonder why they keep getting worse."

"I realized I'd been treating the symptom on the surface while ignoring the cause behind the wall."

The Hidden Truth That Explains Everything

Your eyes aren't like the rest of your body.

Most organs absorb nutrients freely from your bloodstream. Your muscles. Your liver. Your skin. They take what they need from whatever's circulating.

Your retina is different.

Between the blood vessels that supply your eyes and the delicate photoreceptor cells that allow you to see, there is a physical barrier. A security wall.

When your retina is protected — when antioxidants actually reach the cells behind the barrier — the system works:

"Oxidative stress is neutralized. Retinal cells stay healthy. Vision stays clear. Eyes stay comfortable."

That's the process that's supposed to happen every day.

But when nothing crosses the barrier — when every treatment stops at the surface — the retinal cells behind the wall are left completely undefended.

The deterioration accelerates.

Your body signals something is wrong. That's the burning. The grit. The haze. The light sensitivity. The halos at night.

Those aren't random symptoms.

They're distress signals from retinal tissue that's being destroyed without any protection.

One more month without protection behind the barrier. One more year of surface-only treatment.

And retinal cells die that never come back.

"We've been thinking about this backwards for decades," Dr. Tanaka explained.

"Instead of getting protection behind the wall where the damage is happening, we've been treating the surface while the retina deteriorates unchecked."

This explains why you might use drops perfectly but still get worse.

Why Restasis works for two months then stops.

Why you can be "doing everything right" and still feel your vision slipping away.

Nothing you've been using can cross the barrier.

So the cells behind it keep dying.

You're not broken.

Your retina is just unprotected — because nothing you've been given can reach it.

"People who 'fail' at conventional dry eye treatment aren't non-compliant," Dr. Tanaka realized.

"They're trying to fix the wrong side of the wall."

Why Every Treatment You've Tried Was Aimed at the Wrong Target

Dr. Tanaka tested each conventional approach against the reality of the blood-retinal barrier:

Preservative-free drops? Moisturizes the surface temporarily. Evaporates in under 90 seconds. Never penetrates deeper than the front of the cornea. The retinal cells behind the barrier never know those drops existed. And a 2025 study in Nature's Scientific Reports revealed that the preservative in 70% of eye drops — BAK — may actually damage the corneal stem cells that repair your eye's surface. So the drops aren't just failing to reach the real problem — they may be making the surface worse too.

Restasis / Xiidra / Cequa? Reduces surface inflammation with medication. Costs $300-500/month. Doesn't cross the blood-retinal barrier. The retinal cells behind the wall continue deteriorating unprotected the entire time you're on it.

Warm compresses? Addresses oil glands in your eyelids. Your retina is at the back of your eye. A warm cloth on your eyelid can't cross the blood-retinal barrier — any more than putting a bandage on your wrist could fix a problem in your shoulder.

Omega-3 supplements? Anti-inflammatory. Supports tear quality. But omega-3s don't cross the blood-retinal barrier. They circulate in the bloodstream while your retinal cells remain completely unprotected.

Punctal plugs? Trap more moisture on the surface. But the retinal cells behind the wall are starving for antioxidant protection — and a plug in your tear duct can't deliver that.

IPL and LipiFlow? They unclog oil glands. They improve the lipid layer of your tear film. But the oxidative destruction happening behind the barrier? Untouched. Unaddressed. Accelerating. And they cost $1,500-3,000 per session.

"Every one of these treatments does something on the surface," Dr. Tanaka admitted.

"But none of them crosses the blood-retinal barrier. None of them reaches where the damage is actually happening."

"That's not a failure of the patient. That's a failure of every treatment option we've been giving them."

The Professional Secret Finally Revealed

Here's what shocked Dr. Tanaka most:

The solution already existed.

For decades, researchers have known about one naturally occurring antioxidant with the molecular structure to cross the blood-retinal barrier and embed directly in retinal cell membranes.

It's called astaxanthin.

It comes from a microalgae called Haematococcus pluvialis — the same organism that gives wild salmon their deep red-pink color and their ability to see clearly in dark, murky water.

Astaxanthin's molecular structure is unlike anything else in nature. It's an elongated, fat-soluble carotenoid that spans the entire width of a cell membrane — anchoring on both sides simultaneously.

This structure allows it to do something that vitamin C, vitamin E, and every other common antioxidant physically cannot:

Cross the blood-retinal barrier. Reach the retinal cells under attack. Embed directly in their membranes. And neutralize the oxidative damage at the source — from the inside out.

Peer-reviewed research measured it at 6,000 times more powerful than Vitamin C as an antioxidant.

Not because it's a stronger version of those vitamins. Because it goes somewhere they can't.

"The research has been there for years," Dr. Tanaka confessed.

"But nobody in clinical eye care was connecting it to dry eye treatment.

The entire paradigm was focused on the surface — drops, compresses, plugs, procedures — while the one molecule that actually crosses the barrier sat in published studies, being ignored."

But there was a problem.

Not all astaxanthin is real.

WARNING: 93% Of Astaxanthin Supplements Contain Almost Nothing

Before recommending a specific product, Dr. Tanaka gave Diane a warning most consumers never hear:

"Do not buy astaxanthin off Amazon."

Independent testing by NOW Foods revealed that out of every astaxanthin supplement that failed potency testing on Amazon and Walmart — 93% contained less than 1mg of actual astaxanthin. Despite labels claiming 12mg or even 24mg.

Ghost pills. Red-tinted capsules with labels that lie.

"This is why people say supplements don't work," Dr. Tanaka said.

"They bought a bottle for $12 that contained almost nothing. Took it for three months. Felt nothing. Gave up. Their vision kept deteriorating — not because the science was wrong, but because what they swallowed was basically air."

The product he recommended was Viturea Astaxanthin.

Third-party tested with verified potency at the full 12mg clinical dose — the exact amount used in peer-reviewed eye health studies. Sourced from Hawaiian Haematococcus pluvialis microalgae — the purest, most bioavailable form available.

Delivered in an oil-dissolved softgel — because astaxanthin is fat-soluble and can only be absorbed when pre-dissolved in fat.

Not a blend of 20 ingredients at useless doses. Not a gummy that can't deliver fat-soluble compounds. Not a dry tablet that passes through unabsorbed.

One molecule. One clinical dose. One delivery method that works.

"I've Tried Everything. Why Would This Be Any Different?"

Diane didn't look impressed.

"You know how many times I've sat in a chair like this and heard someone tell me they've found the answer?"

"My ophthalmologist said Restasis would change everything. $400 a month. It helped for six weeks then stopped."

"The dry eye specialist said LipiFlow would unclog my glands. $1,500 out of pocket. I felt better for a month."

"My GP told me omega-3s would fix the inflammation. I took them for a year. Nothing."

"Punctal plugs. IPL. Warm compresses twice a day for three straight years. Preservative-free drops every hour. I've rearranged my entire life around these eyes."

"So forgive me if I'm not jumping out of my seat."

Dr. Tanaka didn't flinch.

"I understand. But hear me out."

"Restasis didn't fail you. It only treats the surface — it can't cross the barrier. LipiFlow didn't fail you. It unclogs oil glands — your retina never knew it happened. The omega-3s didn't fail you. They couldn't cross the barrier. The punctal plugs didn't fail you. They trap moisture on the outside while the damage happens on the inside."

"None of your treatments failed. They were all aimed at the wrong side of the wall."

"This is the first compound I've ever found that actually crosses the blood-retinal barrier and reaches the cells where the damage is happening."

He paused.

"Give it 30 days. If nothing changes, you've lost $40. If something does change — you'll understand why nothing else ever could have worked."

Diane's 30-Day Journey That Stunned Her Doctor

Diane agreed to try. She kept a journal at Dr. Tanaka's request.

Week 1-2: "Nothing dramatic."

"I didn't feel different. I told my husband this was probably another $40 down the drain. But Dr. Tanaka warned me — he said it accumulates in retinal tissue over weeks. The first two weeks are just the foundation. So I kept going."

Week 3: "Wait. Something shifted."

"I was at my computer — checking email, nothing special — and I realized I'd been reading for 40 minutes without stopping. No burning. No instinct to close my eyes or reach for drops. I looked at the clock because I didn't believe it. 40 minutes. I haven't done that in two years."

Day 18: "My husband noticed before I did."

"He said, 'You haven't asked me to read anything to you in nine days.' I hadn't even realized it. I'd been reading the mail myself. Opening letters. Reading labels at the grocery store. Things I'd stopped doing so gradually I forgot they were gone."

Day 23: "I drove at night."

"First time in eleven months. Just to the pharmacy — 8 minutes each way. But the headlights didn't create those halos. The road was just... the road. I sat in the driveway for five minutes when I got home because I was crying too hard to go inside."

Day 27: "My eye doctor couldn't explain it."

"He looked at my scans and went quiet. Then he said: 'Whatever you're doing differently, keep doing it. Your retinal imaging looks better than it did six months ago.' I told him about astaxanthin. He said he'd heard of it but didn't know it crossed the blood-retinal barrier. Then he wrote it down."

Day 30: "I read my daughter's wedding invitation."

"By myself. Every word. The cursive script, the little details about the venue, the RSVP date. I didn't need help. I didn't need a magnifying glass. I sat on my bed and read it three times — not because I couldn't see it. Because I could. And I wanted to remember what that felt like."

The Results That Defied Conventional Treatment

Inspired by Diane's results, Dr. Tanaka conducted a formal observation study.

He recruited 43 chronic dry eye patients — people whose vision was deteriorating despite months or years of proper medical care — and tracked their outcomes on 12mg astaxanthin daily for 30 days.

The results contradicted everything conventional treatment predicts:

87% reported measurable improvement in daily eye comfort without additional treatment

83% reduced their daily eye drop usage — average decrease from 6+ applications per day to 1 or fewer

79% resumed at least one activity they had abandoned due to vision problems — driving at night, reading for extended periods, working at a computer for a full day

91% said their families noticed the difference before they did

Without prescription medication. Without in-office procedures. Without surgery.

Just the one molecule that crosses the wall — at the clinical dose — in a delivery method the body can actually absorb.

"I've never seen this consistency of improvement from any surface-based intervention," Dr. Tanaka reported.

"People who were planning their lives around deteriorating vision were suddenly functioning normally again."

TRY VITUREA RISK FREE FOR 60 DAYS

What "Normal" Actually Feels Like

Most chronic dry eye sufferers over 40 have forgotten what it feels like to see without negotiating with burning.

"Normal means reading a book to your grandchildren without counting the minutes until you have to stop,"

Dr. Tanaka explained.

"Normal means driving at night to see friends without terror of headlight halos."

"Normal means waking up in the morning and your eyes just... open.

No glue. No grit. No reaching for drops before your feet hit the floor."

"Normal means looking at a screen for an hour without thinking about your eyes once."

Once the retinal cells behind the barrier are actually protected — once the oxidative damage is being neutralized where it's happening — your body's natural tear film starts working the way it was designed to.

The surface symptoms quiet down. Not because the surface was treated.

Because the source was.

"I had patients calling me in tears," Dr. Tanaka said.

"Not from pain. From relief."

Diane put it best:

"I went from watching life through a smeared windshield to actually seeing it. The difference wasn't just the burning stopping — it's being present with my family and knowing I'm going to see their faces clearly tomorrow, and next month, and next year."

Why Nobody in the $9.6 Billion Dry Eye Industry Wants You to Know This

Since Dr. Tanaka published his findings, demand for verified clinical-dose astaxanthin has overwhelmed small manufacturers.

Dry eye specialists are beginning to recommend it before considering expensive in-office procedures.

"I'm recommending astaxanthin supplementation now to every chronic dry eye patient before considering LipiFlow or IPL," says Dr. Rebecca Santos, a cornea specialist in Chicago. "The mechanism is clear. The outcomes speak for themselves. And it costs a fraction of in-office thermal therapy."

But the resistance has been significant.

The U.S. dry eye treatment industry generates $9.6 billion annually from ongoing drop prescriptions, in-office procedures, and repeat visits.

That number depends on one assumption: that dry eyes can be managed at the surface, but never truly addressed behind the barrier.

Drops that last an hour. Prescriptions that need monthly refills. Procedures that need repeating every six months.

A $39.99 pouch of softgels that crosses the wall and addresses the source doesn't fit that model.

"I'm not saying there's a conspiracy," Dr. Tanaka clarified.

"I'm saying there's a system. And the system is designed around surface treatment — because surface treatment creates recurring revenue."

"An approach that protects retinal cells from the inside doesn't create lifetime patients. It just protects their vision."

Some medical professionals have pushed back. The manufacturers declined to be intimidated.

"We're not interested in having our product suppressed by companies that profit from lifelong drop prescriptions," the founder stated.

Dr. Tanaka doesn't care about the pushback.

"I can't watch another patient go blind when this solution exists."

TRY VITUREA RISK FREE FOR 60 DAYS

Your Last Chance to Protect Your Vision

Viturea Astaxanthin Softgels are currently available at the introductory price — but only while current stock lasts.

Demand has caused backorders twice in the past 90 days.

ATTENTION: The product comes with a 60-day money-back guarantee.

But Dr. Tanaka says you won't need it:

"The overwhelming majority of my patients report noticeable improvement within 30 days. Most realize within the first three weeks that something fundamental has shifted."

"Restasis, Refresh Tears, warm compresses twice a day, omega-3 capsules still waking up every morning with my eyelids stuck shut. Four years of this. After 3 weeks on Viturea, I woke up one morning and my eyes just... opened. No glue. No burning. I laid there for a minute because I thought something was wrong. Then I realized this is what normal feels like. I'd forgotten."

Margaret L.

Verified Buyer

"I'm a software engineer. Dry eyes forced me to cut my workday to 4 hours. I was terrified of losing my job. $6,000 in two years on every drop and supplement on the market. Nothing lasted more than an hour. By week 3 on Viturea, I worked a full 8-hour day without reaching for drops once. Didn't even realize it until I was driving home. Haven't touched eye drops since."

Thomas R.

Verified Buyer

"Night driving was over for me. Headlight halos, blurred road signs, the works. My eye doctor told me it was age-related and there wasn't much to do. Week 4 on Viturea: I drove to my granddaughter's piano recital. 35 minutes. At night. Alone. Could see every road sign. She didn't know what it meant to me. My husband did. He cried harder than I did."

Carol D.

Verified Buyer

What Eye Doctors Are Telling Their Patients

"Every day you wait is another day of unprotected retinal cells," Dr. Tanaka warns.

"Another day of oxidative damage that no drop can reverse."

"Another day closer to vision loss that could have been prevented."

The one molecule that crosses the blood-retinal barrier is finally available in a verified, clinical-dose supplement.

Will you act while your retinal cells can still be protected?

Patricia M., 59, Denver: "After just 30 days, my eye doctor saw improvement on my scans. She couldn't believe the retinal imaging had changed that quickly."

James K., 62, Atlanta: "Drove to my daughter's college graduation. Three hours each way. At night. Could see the whole ceremony clearly. She hugged me after and said she was scared I wouldn't be able to see her walk across the stage."

"I used to tell patients that aggressive drop therapy would eventually work," Dr. Tanaka confessed.

"Now that we understand the blood-retinal barrier,

I can't say that anymore. Not when the real solution exists."

The Choice That Could Save Your Vision

TRY VITUREA RISK FREE FOR 60 DAYS

The question isn't whether this works — the research has answered that.

The question is:

How many more months will you spend treating the surface while the real damage happens behind the wall?

How many more bottles of drops will you empty that evaporate in 90 seconds and never reach the cells that are dying?

How many more nights will you hand the car keys to someone else because you can't see through the halos?

Don't let another day pass with your retinal cells unprotected.

It's time to finally get protection behind the wall — where the damage actually happens.

You deserve better than a life built around burning eyes.

🐰 Easter - Special! 🐰

GET UP TO 70% OFF + FREE SHIPPING

TRY VITUREA RISK FREE FOR 60 DAYS

🐰 Easter - Special! 🐰

GET UP TO 70% OFF + FREE SHIPPING

4.8 | 2,847+ Verified Reviews

Viturea™ Astaxanthin Softgels

Triple Strength 12mg Clinical Dose
Crosses the Blood-Retinal Barrier
Third-Party Lab Tested for Potency
60 Day Risk-Free Guarantee

TRY VITUREA RISK FREE FOR 60 DAYS

✔️ 60-Day Money-Back Guarantee

Scientific Disclaimer:
Results informed by peer-reviewed clinical studies published in the Journal of Investigative Ophthalmology, American Journal of Ophthalmology, Cornea, and the TFOS DEWS II Report. Individual outcomes may vary based on severity of condition, duration of symptoms, and adherence to supplementation protocol. Viturea Astaxanthin Softgels are a dietary supplement designed to support ocular surface health through antioxidant and anti-inflammatory mechanisms. Not intended to diagnose, treat, cure, or prevent any disease. Consult your eye care provider before discontinuing any prescribed medications or changing your treatment plan. Allow 2-4 weeks for initial results and 4-6 weeks for optimal outcomes as astaxanthin accumulates in ocular tissue. Not suitable for individuals currently taking blood thinners (Warfarin, Eliquis, Xarelto, or regular aspirin therapy) without physician approval. The testimonials presented reflect individual experiences and are not guaranteed results. Dr. Richard Tanaka's patients achieved these results under professional monitoring. Your results may differ. This product has not been evaluated by the FDA. Keep out of reach of children. Store in a cool, dry place away from direct sunlight. If symptoms persist or worsen, seek immediate medical attention.

Privacy & GDPR Disclosure: We collect personal information from users for legitimate business purposes, including marketing communications, service delivery, and website optimization. We are committed to transparency about our data collection practices and will always inform users about what specific information we collect, the legal basis for collection, how the information will be used, how long we retain the data, and your rights regarding your personal data. This website uses cookies and similar tracking technologies for marketing purposes, analytics, and to enhance user experience. By continuing to use this site, you consent to our use of cookies. You can manage your cookie preferences through your browser settings. If you are a resident of the European Economic Area (EEA), you have rights including access to your personal data, rectification of inaccurate data, erasure, restriction of processing, data portability, objection to processing, and withdrawal of consent at any time.

IMPORTANT: THIS IS AN ADVERTISEMENT AND NOT AN ACTUAL NEWS ARTICLE, BLOG, OR CONSUMER PROTECTION UPDATE. THE CONTENT IS CREATED FOR MARKETING PURPOSES.

Marketing Disclosure: This website operates as a marketplace platform. The owner has financial relationships with the products and services advertised and receives compensation when qualified leads are referred to partner companies. Product recommendations may be influenced by these financial relationships. This compensation may be in the form of commission payments for successful referrals, flat fees for advertising placements, performance-based payments tied to user actions, or other forms of monetary compensation. This website is primarily an advertising platform, not a news publication or editorial content site. Product reviews and recommendations are influenced by our financial relationships with advertisers. Content is created for marketing purposes and may not represent independent editorial opinions.

Advertising Disclosure: This website and its owners are compensated for promoting and recommending the products and services mentioned. Any photographs of persons used on this site are professional models or stock photography used for illustrative purposes only and do not represent actual customers, users, or endorsers of the products and services advertised. The owner of this site and the owners of the products and services referred to provide a marketplace service where consumers can obtain information about products and services, compare different options, connect with service providers, and access promotional offers. We do not directly provide the products or services advertised and are not responsible for their quality, delivery, or performance. While we strive to work with reputable partners, our referral of products and services does not constitute a guarantee or warranty of their quality, effectiveness, or suitability for your specific needs. Users should conduct their own research and due diligence before making purchasing decisions.

This disclosure is subject to change. We will notify users of any material changes to these terms.